-
Scientific American |
The editors of Scientific American argue that the rate of false positives in new genetic tests for fetal disorders could be alarmingly high, and regulations must take this into account.
Mar 2, 2016
-
Tech Times |
The microfluidic device allows a smartphone camera to read the color scale of a blood droplet.
Mar 1, 2016
-
Bio-IT World | NanoString Technologies, a
Seattle company with a small but comfortable niche in automated genetic
analysis, is preparing to make the leap into DNA and RNA sequencing,
with a highly novel process it calls Hyb and Seq.
Feb 29, 2016
-
Xconomy |
The experimental test is based on the idea that lung cancer cells in sputum will differentially absorb a fluorescent molecule, providing an inexpensive confirmation after a CT scan.
Feb 25, 2016
-
Diagnostics World News Brief | An international task force has devised new criteria for identifying cases of sepsis, the leading cause of death by infection, which they believe will improve the rate at which the condition is diagnosed and effectively treated.
Feb 25, 2016
-
GEN |
The grant, from the Paul G. Allen Family Foundation, will support the addition of a Zika assay to Chembio's Dual Path Platform for point-of-care testing.
Feb 22, 2016
-
Nature News |
Scientists claim a novel bacterium can cause the tick-borne disease and may trigger more serious symptoms - just the latest entry in a history of research showing the causes of Lyme are not always clear or easy to detect.
Feb 17, 2016
-
Diagnostics World | Atlas Genetics, a point-of-care infectious disease diagnostics company based in Trowbridge, UK, and Boston, Mass., has received its first regulatory approval, a CE Mark for a chlamydia test that will now be available for sale in Europe.
Feb 17, 2016
-
Washington Business Journal |
The venture arm of China's largest insurer led a Series A funding round for 20/20 Gene Systems, which emphasizes early cancer detection and sees a promising market in Asia.
Feb 15, 2016
-
Diagnostics World | Immunovia, a Swedish firm developing microarrays with biomarker signatures, this week announced the latest of three recent collaborations to validate an early detection blood test for pancreatic cancer in a prospective clinical study.
Feb 12, 2016
-
Diagnostics World Brief | Grail has a CEO with a compelling story and a high tech background. The Illumina spinoff has named Jeff Huber, formerly of Google, as chief executive. Grail's goal is a liquid biopsy cancer test--ideally a standard-of-care blood test that would alert physicians to circulating cancerous cells long before the patient is symptomatic. The test, if it existed, might have saved the life of Laura Huber, Jeff's wife, who died in November of aggressive colon cancer.
Feb 10, 2016
-
MedCity News | Cofactor Genomics, a diagnostic sequencing company spun off from the Genome Institute at Washington University, has acquired Narus biotechnologies, which is searching for RNA biomarkers in a variety of neurological diseases.
Feb 8, 2016
-
New York Times |
The $5.8 billion acquisition of Alere, which makes point-of-care medical tests, will enhance Abbott's diagnostics business.
Feb 4, 2016
-
Bio-IT World | The results of a months-long effort to sequence virus samples in the
middle of the largest Ebola outbreak in history, using the handheld
MinION DNA sequencer and a miniature mobile lab, have been published in Nature.
Feb 3, 2016
-
Diagnostics World | HealthMyne, a three-year-old Madison, Wis., based startup has teamed up with Epic Systems and UW Health to integrate its informatics platform with electronic health record (EHR) data – a move intended to help radiologists better monitor cancer treatment progress.
Feb 2, 2016
-
Outbreak News Today |
The CDC held a briefing in which Director Anthony Fauci of the National Institutes for Allergy and Infectious Diseases spoke about approaches to creating a Zika virus diagnostic.
Jan 29, 2016
-
Gizmodo |
A handheld microscope designed at the University of Washington produces rapid imaging of tissues at a resolution that its creators say could be enough to identify tumor cells.
Jan 26, 2016
-
Wall Street Journal |
John Carreyrou reports that U.S. health inspectors have found serious deficiencies at Theranos' laboratory in Northern California, and uncovers new details about outsourcing of tests and the agreement tying the company to Walgreens.
Jan 25, 2016
-
Diagnostics World | Oracle Health Sciences today announced Oracle Healthcare Precision Medicine, a software solution to connect genetic testing, report generation, and clinical care decision-making.
Jan 25, 2016
-
STAT |
A huge trial of personalized cancer medicine has run into an unexpected roadblock: many tumor samples aren't robust enough to put through genetic analysis.
Jan 22, 2016